- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06394739
RevCore for In Stent Thrombosis (REVIT)
RevCore for In Stent Trombose (REVIT)
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Studieoversigt
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Jenifer Foss
- Telefonnummer: (978)-587-6598
- E-mail: jenifer.foss@stryker.com
Studiesteder
-
-
Connecticut
-
New Haven, Connecticut, Forenede Stater, 06511
- Rekruttering
- Yale University
-
Kontakt:
- Angelo Marino, OD
-
Ledende efterforsker:
- Angelo Marino, OD
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forenede Stater, 20010
- Rekruttering
- Medstar Health Research Institute
-
Ledende efterforsker:
- Kyle Reynolds, MD
-
Underforsker:
- Steven Abramowitz
-
Kontakt:
- Kyle Reynolds, MD
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83712
- Rekruttering
- St. Luke's Hospital Boise
-
Kontakt:
- Tyler Harris, MD
-
Ledende efterforsker:
- Tyler Harris, MD
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- Aktiv, ikke rekrutterende
- University of Maryland
-
-
New York
-
New York, New York, Forenede Stater, 10016
- Rekruttering
- New York University- Langone
-
Ledende efterforsker:
- Mikel Sadek, MD
-
Kontakt:
- Mikel Sadek, MD
-
-
North Carolina
-
Asheville, North Carolina, Forenede Stater, 28801
- Rekruttering
- Mission Health
-
Ledende efterforsker:
- Trevor Downing, MD
-
Kontakt:
- Trevor Downing, MD
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44106
- Rekruttering
- UH Cleveland Medical Center
-
Ledende efterforsker:
- Karem Harth, MD
-
Kontakt:
- Karem Harth, MD
-
Columbus, Ohio, Forenede Stater, 23210
- Rekruttering
- Ohio State University
-
Ledende efterforsker:
- Mina Makary, MD
-
Kontakt:
- Mina Makary, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Rekruttering
- University of Pennsylvania
-
Kontakt:
- Ryan Cobb, MD
-
Ledende efterforsker:
- Ryan Cobb, MD
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Trukket tilbage
- Thomas Jefferson University
-
Pittsburgh, Pennsylvania, Forenede Stater, 15212
- Rekruttering
- Allegheny Health Network Research Institute
-
Kontakt:
- Abdullah Shaikh, MD
-
Ledende efterforsker:
- Abdullah Shaikh, MD
-
-
South Carolina
-
Spartanburg, South Carolina, Forenede Stater, 29303
- Rekruttering
- Spartanburg Medical Center
-
Ledende efterforsker:
- Brian Brown, MD
-
Kontakt:
- Brian Brown, MD
-
-
Texas
-
El Paso, Texas, Forenede Stater, 79902
- Rekruttering
- El Paso Cardiology Associates
-
Kontakt:
- Waseem Shami, MD
-
Ledende efterforsker:
- Waseem Shami, MD
-
Plano, Texas, Forenede Stater, 75093
- Rekruttering
- Baylor Scott & White Research Institute
-
Kontakt:
- Joseph Liechty, MD
-
-
Virginia
-
Norfolk, Virginia, Forenede Stater, 23507
- Rekruttering
- Sentara
-
Ledende efterforsker:
- David Dexter, MD
-
Kontakt:
- David Dexter, MD
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98133
- Rekruttering
- University of Washington
-
Kontakt:
- Jake Hemingway, MD
-
Ledende efterforsker:
- Jake Hemingway, MD
-
-
West Virginia
-
Morgantown, West Virginia, Forenede Stater, 26506
- Rekruttering
- West Virginia University- Ruby Memorial
-
Kontakt:
- Robert Grammer, MD
-
Ledende efterforsker:
- Robert Grammer, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Up to 100 subjects with in-stent thrombosis will be enrolled. All subjects who sign informed consent and who meet all of the inclusion criteria and none of the exclusion criteria will be eligible to participate in the study.
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years
- Patients with stent age > 6 weeks
- Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
- RevCore Thrombectomy Catheter must enter vasculature
- Willing and able to provide informed consent
Exclusion Criteria:
- Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
- Stents not wall apposed
- Stents compressed to <10mm
- Bilateral in-stent thrombosis
- Congenital anatomic anomalies of the iliac veins
- Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
- Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Chronic non-ambulatory status
- Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Inability to secure venous access
- Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
- Current participation in another investigational drug or device treatment study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Evidence of successful stent recanalization
Tidsramme: Immediately after the RevCore thrombectomy procedure for in-stent thrombosis
|
Defined as patency ≥50% luminal diameter utilizing intravascular ultrasound (IVUS) |
Immediately after the RevCore thrombectomy procedure for in-stent thrombosis
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 23-002 REVIT
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .